These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Atrial natriuretic peptide in patent ductus arteriosus. Andersson S, Tikkanen I, Pesonen E, Meretoja O, Hynynen M, Fyhrquist F. Pediatr Res; 1987 Apr; 21(4):396-8. PubMed ID: 2952937 [Abstract] [Full Text] [Related]
4. Atrial natriuretic peptide in newborn piglets with a patent ductus arteriosus. Malone TA, Stonestreet BS, Goddard M, Sicard R, Werner JC, Oh W. Dev Pharmacol Ther; 1992 Apr; 19(2-3):155-60. PubMed ID: 1340436 [Abstract] [Full Text] [Related]
5. Cardiovascular biomarkers pro-atrial natriuretic peptide and pro-endothelin-1 to monitor ductus arteriosus evolution in very preterm infants. Grass B, Baumann P, Arlettaz R, Fouzas S, Meyer P, Spanaus K, Wellmann S. Early Hum Dev; 2014 Jun; 90(6):293-8. PubMed ID: 24661445 [Abstract] [Full Text] [Related]
6. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus. Letzner J, Berger F, Schwabe S, Benzing J, Morgenthaler NG, Bucher HU, Bührer C, Arlettaz R, Wellmann S. Neonatology; 2012 Jun; 101(2):116-24. PubMed ID: 21952518 [Abstract] [Full Text] [Related]
7. Correlation of patent ductus arteriosus shunting with plasma atrial natriuretic factor concentration in preterm infants with respiratory distress syndrome. Pesonen E, Merritt AT, Heldt G, Sahn DJ, Elias W, Tikkanen I, Fyhrquist F, Andersson S. Pediatr Res; 1990 Feb; 27(2):137-9. PubMed ID: 2138278 [Abstract] [Full Text] [Related]
9. Longitudinal changes of brain-type natriuretic peptide in preterm neonates. da Graca RL, Hassinger DC, Flynn PA, Sison CP, Nesin M, Auld PA. Pediatrics; 2006 Jun; 117(6):2183-9. PubMed ID: 16740863 [Abstract] [Full Text] [Related]
10. Aminoterminal B-type natriuretic peptide (NT-proBNP) in the therapy of patent ductus arteriosus. Bagnoli F, Rossetti A, Casucci M, Mori A. Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):67-70. PubMed ID: 21089722 [Abstract] [Full Text] [Related]
16. Outcome of patent ductus arteriosus ligation in premature infants in the East of England: a prospective cohort study. Kang SL, Samsudin S, Kuruvilla M, Dhelaria A, Kent S, Kelsall WA. Cardiol Young; 2013 Oct; 23(5):711-6. PubMed ID: 23164413 [Abstract] [Full Text] [Related]
17. Surgical ligation of patent ductus arteriosus in premature infants: trends and practice variation. Weinberg JG, Evans FJ, Burns KM, Pearson GD, Kaltman JR. Cardiol Young; 2016 Aug; 26(6):1107-14. PubMed ID: 26395077 [Abstract] [Full Text] [Related]
18. Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage. El-Khuffash A, Barry D, Walsh K, Davis PG, Molloy EJ. Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F407-12. PubMed ID: 18285375 [Abstract] [Full Text] [Related]
19. Patent ductus arteriosus ligation is associated with impaired left ventricular systolic performance in premature infants weighing less than 1000 g. McNamara PJ, Stewart L, Shivananda SP, Stephens D, Sehgal A. J Thorac Cardiovasc Surg; 2010 Jul; 140(1):150-7. PubMed ID: 20363478 [Abstract] [Full Text] [Related]
20. Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants. Amitai Y, Hammerman C. Arch Dis Child Fetal Neonatal Ed; 2012 Jan; 97(1):F76. PubMed ID: 22090351 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]